Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature

Journal of Molecular and Cellular Cardiology

Volumn 60, Issue 1, 2013, Pages 16-26

  Demyanets, Svitlana ^a   Kaun, Christoph ^a   Pentz, Richard ^a   Krychtiuk, Konstantin A ^a,b   Rauscher, Sabine ^a,c   Pfaffenberger, Stefan ^a   Zuckermann, Andreas ^a   Aliabadi, Arezu ^a   Gröger, Marion ^a,c   Maurer, Gerald ^a   Huber, Kurt ^d   Wojta, Johann ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d WILHELMINEN HOSPITAL   (Austria)

Author keywords

Cardiac fibroblasts; Cardiac myocytes; Cytokines; Interleukin 33; ST2

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; FUMARIC ACID DIMETHYL ESTER; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 33; INTERLEUKIN RECEPTOR; ISOPROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ST2; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CARDIOMYOPATHY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; FIBROBLAST; GENE; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IL 33 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ST2 GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; BUTADIENES; CELL NUCLEUS; CELLS, CULTURED; CORONARY VESSELS; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B P50 SUBUNIT; NITRILES; ORGAN SPECIFICITY; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

EID: 84877011334     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.03.020     Document Type: Article

References (61)

1. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
2. Dinarello C.A. Historical insights into cytokines. Eur J Immunol 2007, 37(Suppl. 1):S34-S45.
3. Iwahana H., Yanagisawa K., Ito-Kosaka A., Kuroiwa K., Tago K., Komatsu N., et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur J Biochem 1999, 264:397-406.
4. Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007, 179:2551-2555.
5. Miller A.M. Role of IL-33 in inflammation and disease. J Inflamm (Lond) 2011, 8:22.
6. Weinberg E.O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J.L., Lee R.T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003, 107:721-726.
7. Shimpo M., Morrow D.A., Weinberg E.O., Sabatine M.S., Murphy S.A., Antman E.M., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 2004, 109:2186-2190.
8. Kuchler A.M., Pollheimer J., Balogh J., Sponheim J., Manley L., Sorensen D.R., et al. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. Am J Pathol 2008, 173:1229-1242.
9. Moussion C., Ortega N., Girard J.P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?. PLoS One 2008, 3:e3331.
10. Yasuoka S., Kawanokuchi J., Parajuli B., Jin S., Doi Y., Noda M., et al. Production and functions of IL-33 in the central nervous system. Brain Res 2011, 1385:8-17.
11. Demyanets S., Konya V., Kastl S.P., Kaun C., Rauscher S., Niessner A., et al. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2011, 31:2080-2089.
12. Zeyda M., Wernly B., Demyanets S., Kaun C., Hammerle M., Hantusch B., et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes (Lond) 2012, [Epub ahead of print].
13. Baekkevold E.S., Roussigne M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003, 163:69-79.
14. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 2007, 104:282-287.
15. Prefontaine D., Lajoie-Kadoch S., Foley S., Audusseau S., Olivenstein R., Halayko A.J., et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009, 183:5094-5103.
16. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N., Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007, 117:1538-1549.
17. Theoharides T.C., Zhang B., Kempuraj D., Tagen M., Vasiadi M., Angelidou A., et al. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A 2010, 107:4448-4453.
18. Pastorelli L., Garg R.R., Hoang S.B., Spina L., Mattioli B., Scarpa M., et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci U S A 2010, 107:8017-8022.
19. Hudson C.A., Christophi G.P., Gruber R.C., Wilmore J.R., Lawrence D.A., Massa P.T. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 2008, 84:631-643.
20. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
21. Ohno T., Oboki K., Kajiwara N., Morii E., Aozasa K., Flavell R.A., et al. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 2009, 183:7890-7897.
22. Ohno T., Oboki K., Morita H., Kajiwara N., Arae K., Tanaka S., et al. Paracrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activation. PLoS One 2011, 6:e18404.
23. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 2009, 106:9021-9026.
24. Luthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
25. Zheng Y., Gardner S.E., Clarke M.C. Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2011, 31:2781-2786.
26. Oboki K., Ohno T., Kajiwara N., Saito H., Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010, 59:143-160.
27. Barlow J.L., McKenzie A.N. Nuocytes: expanding the innate cell repertoire in type-2 immunity. J Leukoc Biol 2011, 90:867-874.
28. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10:103-110.
29. Kurowska-Stolarska M., Stolarski B., Kewin P., Murphy G., Corrigan C.J., Ying S., et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009, 183:6469-6477.
30. Aoki S., Hayakawa M., Ozaki H., Takezako N., Obata H., Ibaraki N., et al. ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells. Mol Cell Biochem 2010, 335:75-81.
31. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., et al. IL-33 reduces the development of atherosclerosis. J Exp Med 2008, 205:339-346.
32. Mildner M., Storka A., Lichtenauer M., Mlitz V., Ghannadan M., Hoetzenecker K., et al. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res 2010, 87:769-777.
33. Choi Y.S., Choi H.J., Min J.K., Pyun B.J., Maeng Y.S., Park H., et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 2009, 114:3117-3126.
34. Masamune A., Watanabe T., Kikuta K., Satoh K., Kanno A., Shimosegawa T. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2010, 299:G821-G832.
35. Wood I.S., Wang B., Trayhurn P. IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem Biophys Res Commun 2009, 384:105-109.
36. Onda H., Kasuya H., Takakura K., Hori T., Imaizumi T., Takeuchi T., et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1999, 19:1279-1288.
37. Nile C.J., Barksby E., Jitprasertwong P., Preshaw P.M., Taylor J.J. Expression and regulation of interleukin-33 in human monocytes. Immunology 2010, 130:172-180.
38. Bartunek J., Delrue L., Van Durme F., Muller O., Casselman F., De Wiest B., et al. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol 2008, 52:2166-2174.
39. Macfelda K., Weiss T.W., Kaun C., Breuss J.M., Zorn G., Oberndorfer U., et al. Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes. J Mol Cell Cardiol 2002, 34:1681-1691.
40. Demyanets S., Kaun C., Rychli K., Pfaffenberger S., Kastl S.P., Hohensinner P.J., et al. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-gamma. Basic Res Cardiol 2011, 106:217-231.
41. Enoksson M., Lyberg K., Moller-Westerberg C., Fallon P.G., Nilsson G., Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 2011, 186:2523-2528.
42. Loewe R., Holnthoner W., Groger M., Pillinger M., Gruber F., Mechtcheriakova D., et al. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells. J Immunol 2002, 168:4781-4787.
43. Demyanets S., Pfaffenberger S., Kaun C., Rega G., Speidl W.S., Kastl S.P., et al. The estrogen metabolite 17beta-dihydroequilenin counteracts interleukin-1alpha induced expression of inflammatory mediators in human endothelial cells in vitro via NF-kappaB pathway. Thromb Haemost 2006, 95:107-116.
44. Liu L., Zhao S.P. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy. Int J Cardiol 1999, 69:77-82.
45. Guan X., Yang W., Sun X., Wang L., Ma B., Li H., et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res 2012, 61:591-598.
46. Pasini A.F., Anselmi M., Garbin U., Franchi E., Stranieri C., Nava M.C., et al. Enhanced levels of oxidized low-density lipoprotein prime monocytes to cytokine overproduction via upregulation of CD14 and toll-like receptor 4 in unstable angina. Arterioscler Thromb Vasc Biol 2007, 27:1991-1997.
47. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996, 27:1201-1206.
48. Alvarez-Guardia D., Palomer X., Coll T., Davidson M.M., Chan T.O., Feldman A.M., et al. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc Res 2010, 87:449-458.
49. Dhillon O.S., Narayan H.K., Khan S.Q., Kelly D., Quinn P.A., Squire I.B., et al. Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?. Int J Cardiol 2012, [Epub ahead of print].
50. Xu D., Jiang H.R., Kewin P., Li Y., Mu R., Fraser A.R., et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 2008, 105:10913-10918.
51. Verhelst K., Carpentier I., Beyaert R. Regulation of TNF-induced NF-kappaB activation by different cytoplasmic ubiquitination events. Cytokine Growth Factor Rev 2011, 22:277-286.
52. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
53. Meephansan J., Tsuda H., Komine M., Tominaga S.I., Ohtsuki M. Regulation of IL-33 expression by IFN-gamma and tumor necrosis factor-alpha in normal human epidermal keratinocytes. J Invest Dermatol 2012, 132:2593-2600.
54. Manetti M., Ibba-Manneschi L., Liakouli V., Guiducci S., Milia A.F., Benelli G., et al. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 2010, 69:598-605.
55. Chang Y.J., Kim H.Y., Albacker L.A., Baumgarth N., McKenzie A.N., Smith D.E., et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011, 12:631-638.
56. Yanagawa Y., Matsumoto M., Togashi H. Adrenoceptor-mediated enhancement of interleukin-33 production by dendritic cells. Brain Behav Immun 2011, 25:1427-1433.
57. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Kuchler A.M. Interleukin-33 - cytokine of dual function or novel alarmin?. Trends Immunol 2009, 30:227-233.
58. Kakkar R., Hei H., Dobner S., Lee R.T. Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 2012, 287:6941-6948.
59. Yagami A., Orihara K., Morita H., Futamura K., Hashimoto N., Matsumoto K., et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 2010, 185:5743-5750.
60. Weinberg E.O., Shimpo M., De Keulenaer G.W., MacGillivray C., Tominaga S., Solomon S.D., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002, 106:2961-2966.
61. Zhu J., Carver W. Effects of interleukin-33 on cardiac fibroblast gene expression and activity. Cytokine 2012, 58:368-379.